Copenhagen, Hovedstaden, Denmark In 2012 was created Lundbeckfonden Emerge, which is appeared as Corporate Investor. The venture was found in Europe in Denmark. The main department of described Corporate Investor is located in the Copenhagen.
The common things for fund are deals in the range of 10 - 50 millions dollars. The high activity for fund was in 2019. The fund is constantly included in less than 2 deals per year.
Among the most popular portfolio startups of the fund, we may highlight NMD Pharma, AFYX Therapeutics. We can highlight the next thriving fund investment areas, such as Pharmaceutical, Medical. Besides, a startup requires to be at the age of 2-3 years to receive the investment from the fund. The fund has no specific favorite in a number of founders of portfolio startups. For fund there is a match between the country of its foundation and the country of its the most frequent investments - Denmark.
The standard case for the fund is to invest in rounds with 3 partakers. Despite the Lundbeckfonden Emerge, startups are often financed by Novo Seeds, Sofinnova Investments, EASME - EU Executive Agency for SMEs. The meaningful sponsors for the fund in investment in the same round are Novo Seeds, Sofinnova Partners, Sofinnova Investments. In the next rounds fund is usually obtained by Novo Seeds, Sofinnova Partners, INKEF Capital.
Related Funds
| Fund Name | Location |
| 10x | England, London, United Kingdom |
| CapSur Capital | Brazil, São Paulo, Sao Paulo |
| Club Network Investments | Stockholm, Stockholm County, Sweden |
| Die Mobiliar | Bern, Bern, Switzerland |
| FinTech Collective | New York, New York, United States |
| Fulcrum Capital Partners | British Columbia, Canada, Vancouver |
| Hangzhou Xidebao Investment Management | China, Hangzhou, Zhejiang |
| Index Capital | Kansas, Overland Park, United States |
| JW Asset Management | New York, New York, United States |
| MicroAd | Japan, Tokyo |
| National Bank of Canada | NAventures | - |
| Projectile Hero | - |
| Quantlab | Houston, Texas, United States |
| Tainquan Moganshan Guye | China, Hangzhou, Zhejiang |
| TrenLab | Community of Madrid, Madrid, Spain |
| VE Partners | Amsterdam, Noord-Holland, The Netherlands |
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
NMD Pharma | $88M | 15 Nov 2023 | Aarhus, Central Denmark Region, Denmark | ||
| $45M | 04 May 2021 | Denmark, Capital Region of Denmark, Denmark | |||
IO Biotech | $149M | 13 Jan 2021 | Denmark, Capital Region of Denmark | ||
NMD Pharma | $44M | 23 Mar 2018 | Aarhus, Central Denmark Region, Denmark | ||
AFYX Therapeutics | $19M | 09 May 2017 | Denmark, Capital Region of Denmark |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
NMD Pharma | $88M | 15 Nov 2023 | Aarhus, Central Denmark Region, Denmark | ||
| $45M | 04 May 2021 | Denmark, Capital Region of Denmark, Denmark | |||
IO Biotech | $149M | 13 Jan 2021 | Denmark, Capital Region of Denmark | ||
NMD Pharma | $44M | 23 Mar 2018 | Aarhus, Central Denmark Region, Denmark | ||
AFYX Therapeutics | $19M | 09 May 2017 | Denmark, Capital Region of Denmark |
